Log in to save to my catalogue

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered...

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_213494501

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents

About this item

Full title

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Journal title

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.245-254

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

More information

Scope and Contents

Contents

Purpose Pharmacokinetic/pharmacodynamic (PK/PD) models have been shown to be useful in predicting tumor growth rates in mouse xenografts. We applied novel PK/PD models to the published anticancer combination therapies of tumor growth inhibition to simulate synergistic changes in tumor growth rates. The parameters from the PK/PD model were further u...

Alternative Titles

Full title

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_213494501

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_213494501

Other Identifiers

ISSN

0344-5704

E-ISSN

1432-0843

DOI

10.1007/s00280-009-1153-z

How to access this item